Healthcare Professionals
Evera MRI XT DR and VR
Implantable Cardioverter Defibrillators (ICDs)
Your browser is out of date
With an updated browser, you will have a better Medtronic website experience. Update my browser now.
Healthcare Professionals
Implantable Cardioverter Defibrillators (ICDs)
Introducing MRI access. Medtronic’s first MR-conditional ICD.
Contoured. The PhysioCurve™ shape is designed with patient comfort in mind with a 30% reduction* in skin pressure.1
Long-lasting. Up to 25% greater longevity than our Protecta ICD,2† so patients spend more time living, and less time getting device replacements.
Smart. SmartShock™, the most advanced shock reduction suite. Enhanced, so patients receive fewer inappropriate shocks.3
Introducing MRI Access
It is estimated that up to 53 to 64% of ICD patients will have a medical need for an MRI within 10 years.1
Elderly patients are the primary users of MRI. Individuals over age 65 are twice as likely to need an MRI compared to younger patients.2
The potential need for an ICD also increases with age.
Medical and surgical specialties rely on MRI for diagnosis. In fact, MRI is the gold standard diagnostic tool for soft tissue imaging for neurologists, oncologists, and orthopedic surgeons. Your ICD choice today can affect their decisions and diagnostic capabilities tomorrow.
The Evera MRI ICD System with SureScan® technology has met the rigors of clinical evaluation, regulatory review, and FDA approval.
Multiple safety features were designed and incorporated from the ground up:
The two available SureScan lead options for SureScan ICDs include:
The SureScan pacing lead options for use with dual chamber SureScan ICDS include:
For additional information on SureScan Systems, please visit www.mrisurescan.com
Nazarian S, Reynolds M, Ryan M, et al. Estimating the Likelihood of MRI in Patients after ICD Implantation: A 10-Year Prediction Model. J Am Coll Cardiol.March 2015;65(10 Supp):A1090.
Global Industry Analysts, Inc. Magnetic Resonance Imaging (MRI) Equipment – A Global Strategic Business Report. San Jose, CA. 2002.
Gillis AM, Pürerfellner H, Israel CW, et al. Reduction of unnecessary right ventricular pacing due to the managed ventricular pacing (MVP®) mode in patients with symptomatic bradycardia. Benefit for both sinus node disease and AV block indications. Heart Rhythm. 2005;Abstract AB21-1.
Flo, Daniel. Device Shape Analysis. January 2013. Medtronic data on file.
Evera DR/VR ICD Manuals.
Medtronic data on file. November 15, 2012.
Analysis was done on DR devices.
Projected service life estimates are based on accelerated battery discharge data and device modeling as specified. Do not interpret these values as precise numbers.
IMPORTANT INFORMATION ON INDICATIONS, SAFETY AND WARNINGS
For listing of Indications, Contraindications, Warnings, Precautions, and Potential Adverse Events, please refer to the Instructions For Use .